50 related articles for article (PubMed ID: 3302388)
1. [Analysis of heparin cofactor II].
Takahashi K; Yamagishi R; Niwa M; Sakuragawa N
Rinsho Byori; 1987 Apr; Spec No 70():181-6. PubMed ID: 3302388
[No Abstract] [Full Text] [Related]
2. [Antithrombin III and heparin cofactor II].
Kondo S; Niwa M
Rinsho Byori; 1985 Feb; Spec No 61():106-13. PubMed ID: 3839027
[No Abstract] [Full Text] [Related]
3. Heparin cofactor II in patients with deep venous thrombosis under heparin and oral anticoagulant therapy.
Toulon P; Vitoux JF; Capron L; Roncato M; Fiessinger JN; Aiach M
Thromb Res; 1988 Mar; 49(5):497-500. PubMed ID: 3376055
[No Abstract] [Full Text] [Related]
4. Laboratory determination of heparin cofactor II.
Ezenagu LC; Brandt JT
Arch Pathol Lab Med; 1986 Dec; 110(12):1149-51. PubMed ID: 3778142
[TBL] [Abstract][Full Text] [Related]
5. Plasma heparin cofactor II and antithrombin III concentrations in adult nephrotic syndrome.
Hannedouche T; Fischer AM; Blanche P; Tapon-Brétaudière J; Ganeval D
Clin Nephrol; 1987 Dec; 28(6):305-6. PubMed ID: 3442960
[No Abstract] [Full Text] [Related]
6. Heparin cofactor II determination--levels in normals and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation.
Tran TH; Duckert F
Thromb Haemost; 1984 Oct; 52(2):112-6. PubMed ID: 6395434
[TBL] [Abstract][Full Text] [Related]
7. [Standardization of the laboratory method for antithrombin activity measurement].
Okajima K
Rinsho Byori; 2002 Mar; 50(3):283-6. PubMed ID: 11985057
[TBL] [Abstract][Full Text] [Related]
8. Heparin cofactor II and other coagulation inhibitors.
Duckert F
Behring Inst Mitt; 1986 Feb; (79):9-11. PubMed ID: 3755039
[TBL] [Abstract][Full Text] [Related]
9. Turnover study of heparin cofactor II in healthy man.
Sié P; Dupouy D; Pichon J; Boneu B
Thromb Haemost; 1985 Oct; 54(3):635-8. PubMed ID: 3841420
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
[TBL] [Abstract][Full Text] [Related]
11. [The second cofactor of heparin].
Sie P
Ann Biol Clin (Paris); 1987; 45(2):181-3. PubMed ID: 3619144
[TBL] [Abstract][Full Text] [Related]
12. Antithrombin III and heparin cofactor II in patients with chronic renal failure undergoing regular hemodialysis.
Toulon P; Jacquot C; Capron L; Frydman MO; Vignon D; Aiach M
Thromb Haemost; 1987 Jun; 57(3):263-8. PubMed ID: 3660328
[TBL] [Abstract][Full Text] [Related]
13. Activation of heparin cofactor II by heparin and dermatan sulfate.
Tollefsen DM
Nouv Rev Fr Hematol (1978); 1984; 26(4):233-7. PubMed ID: 6548014
[TBL] [Abstract][Full Text] [Related]
14. Heparin cofactor II activity in plasma: application of an automated assay method to the study of a normal adult population.
Andersson TR; Larsen ML; Handeland GF; Abildgaard U
Scand J Haematol; 1986 Jan; 36(1):96-102. PubMed ID: 3754062
[TBL] [Abstract][Full Text] [Related]
15. [The other heparin cofactor].
Sie P; Boneu B
Presse Med; 1987 Feb; 16(4):149-50. PubMed ID: 2950443
[No Abstract] [Full Text] [Related]
16. Coagulation inhibitor levels in pneumonia and stroke: changes due to consumption and acute phase reaction.
Sandset PM; Andersson TR
J Intern Med; 1989 May; 225(5):311-6. PubMed ID: 2471768
[TBL] [Abstract][Full Text] [Related]
17. Plasma heparin cofactor II in alcoholic liver disease.
Andersson TR; Bell H
J Hepatol; 1988 Aug; 7(1):79-84. PubMed ID: 3183355
[TBL] [Abstract][Full Text] [Related]
18. Physicochemical aspects of heparin cofactor II.
Pratt CW; Whinna HC; Meade JB; Treanor RE; Church FC
Ann N Y Acad Sci; 1989; 556():104-15. PubMed ID: 2660681
[No Abstract] [Full Text] [Related]
19. Thrombin-based antithrombin assays show overestimation of antithrombin III activity in patients on heparin therapy due to heparin cofactor II influence.
Bohner J; von Pape KW; Blaurock M
Thromb Haemost; 1994 Mar; 71(3):280-3. PubMed ID: 8029789
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated expression of heparin cofactor II inhibits thrombin-induced cellular responses in fibroblasts and vascular smooth muscle cells.
Hayakawa Y; Hirashima Y; Yamamoto H; Hayashi N; Kurimoto M; Kuwayama N; Endo S
Thromb Res; 2005; 116(4):357-63. PubMed ID: 16038721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
